Department of Orthopaedics, St. Vincent's Hospital Melbourne, VIC, Australia.
Biochem Biophys Res Commun. 2010 Aug 6;398(4):613-8. doi: 10.1016/j.bbrc.2010.05.098. Epub 2010 May 23.
Chondrosarcoma develops as a result of overgrowth of chondrocytes and overproduction of cartilage matrix. It is currently surgically treated, although non-invasive methods are being sought. In this report, pigment epithelium-derived factor (PEDF) induced apoptosis in the chondrosarcoma cell line - JJ012, with upregulation of Bax, Fas, caspase-3 and -6 and downregulation of Bcl-2. Cell cycling was also decreased with decreased expression of p38, p-Akt, p-Erk and JNK1 and increased expression of p73 and E2F1. Furthermore, PEDF increased adhesion of cells to collagen-I, with decreased expression of p-Fak, RhoA and cdc42. Invasion of cells through collagen-I was also reduced by PEDF, with decreased expression of uPAR, MMP-14 and increased expression of PAI-1. These findings seminally indicate that PEDF may have potential as an anti-cancer agent against chondrosarcoma.
软骨肉瘤是由于软骨细胞过度生长和软骨基质过度产生而发展的。目前采用手术治疗,但正在寻找非侵入性方法。在本报告中,色素上皮衍生因子 (PEDF) 诱导软骨肉瘤细胞系 JJ012 凋亡,上调 Bax、Fas、caspase-3 和 -6,下调 Bcl-2。细胞周期也减少,p38、p-Akt、p-Erk 和 JNK1 的表达减少,p73 和 E2F1 的表达增加。此外,PEDF 增加了细胞对胶原蛋白-I 的黏附,p-Fak、RhoA 和 cdc42 的表达降低。PEDF 还减少了细胞通过胶原蛋白-I 的侵袭,uPAR、MMP-14 的表达降低,PAI-1 的表达增加。这些发现初步表明,PEDF 可能具有作为软骨肉瘤抗癌剂的潜力。